CONGENITAL HYPERINSULINISM INTERNATIONAL
Data sourced from IRS 990 public filings
CONGENITAL HYPERINSULINISM INTERNATIONAL Congenital Hyperinsulinism International's mission is to improve the lives of people living with congenital hyperinsulinism (or its consequences),a disorder that causes severe hypoglycemia that can lead to seizures,brain damage,or death, if untreated.
Annual Revenue
$1,275,774
Known Funders
8
Grants Received
14
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $1,275,774 | $1,126,855 | $2,173,955 |
| 2023 | $1,150,291 | $1,043,446 | $1,803,323 |
| 2022 | $1,262,625 | $834,055 | $1,644,315 |
| 2021 | $888,439 | $541,828 | $1,177,701 |
| 2020 | $707,807 | $467,697 | $1,097,548 |
| 2019 | $466,689 | $494,501 | $593,116 |
| 2018 | $355,579 | $382,051 | $618,444 |
| 2017 | $471,505 | $280,408 | $653,182 |
Top Funders
FAIRFIELD, NJ
PENNINGTON, NJ
PENNINGTON, NJ
PENNINGTON, NJ
FAIRFIELD, NJ
PENNINGTON, NJ
PHILADELPHIA, PA
PHILADELPHIA, PA
SUMMIT, NJ
SUMMIT, NJ
Key Personnel
From 2024 IRS 990 filing
TRUDY WARD
Director
PAM WILLIAMS
Director
JUSTYNA MONTEMURRO
Director
MASON SMITH
Treasurer
JULIE SHELDON
Vice President
LAURA SULLIVAN
President
SHEILA BOSE
Secretary
JENNIFER SCHMITT
COO
TAI PASQUINI
CRO
JULIE RASKIN
CEO
Frequently Asked Questions
Other Nonprofits in New Jersey
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.